121 related articles for article (PubMed ID: 9507220)
1. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
Zoja C; Corna D; Benedetti G; Morigi M; Donadelli R; Guglielmotti A; Pinza M; Bertani T; Remuzzi G
Kidney Int; 1998 Mar; 53(3):726-34. PubMed ID: 9507220
[TBL] [Abstract][Full Text] [Related]
2. Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice.
Guglielmotti A; Aquilini L; D'Onofrio E; Rosignoli MT; Milanese C; Pinza M
Clin Exp Rheumatol; 1998; 16(2):149-54. PubMed ID: 9536390
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
[TBL] [Abstract][Full Text] [Related]
4. Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Zoja C; Corna D; Locatelli M; Rottoli D; Pezzotta A; Morigi M; Zanchi C; Buelli S; Guglielmotti A; Perico N; Remuzzi A; Remuzzi G
Nephron; 2015; 129(1):52-61. PubMed ID: 25531096
[TBL] [Abstract][Full Text] [Related]
5. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.
Zoja C; Corna D; Rottoli D; Zanchi C; Abbate M; Remuzzi G
Kidney Int; 2006 Jul; 70(1):97-103. PubMed ID: 16688113
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Guglielmotti A; D'Onofrio E; Coletta I; Aquilini L; Milanese C; Pinza M
Inflamm Res; 2002 May; 51(5):252-8. PubMed ID: 12056513
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease.
Corna D; Morigi M; Facchinetti D; Bertani T; Zoja C; Remuzzi G
Kidney Int; 1997 May; 51(5):1583-9. PubMed ID: 9150476
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
10. Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Steiner JL; Davis JM; McClellan JL; Guglielmotti A; Murphy EA
Cytokine; 2014 Mar; 66(1):60-8. PubMed ID: 24548426
[TBL] [Abstract][Full Text] [Related]
11. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1.
Sironi M; Guglielmotti A; Polentarutti N; Fioretti F; Milanese C; Romano M; Vigini C; Coletta I; Sozzani S; Bernasconi S; Vecchi A; Pinza M; Mantovani A
Eur Cytokine Netw; 1999 Sep; 10(3):437-42. PubMed ID: 10477401
[TBL] [Abstract][Full Text] [Related]
12. The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling.
Paccosi S; Musilli C; Mangano G; Guglielmotti A; Parenti A
Pharmacol Res; 2012 Dec; 66(6):526-35. PubMed ID: 22982961
[TBL] [Abstract][Full Text] [Related]
13. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression.
Chandrasekar B; Troyer DA; Venkatraman JT; Fernandes G
J Autoimmun; 1995 Jun; 8(3):381-93. PubMed ID: 7575999
[TBL] [Abstract][Full Text] [Related]
14. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
Knapp J; Braunstein M; Berg SIT; Shirriff C
Arthritis Res Ther; 2022 Dec; 24(1):267. PubMed ID: 36510250
[TBL] [Abstract][Full Text] [Related]
15. Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Zoja C; Liu XH; Donadelli R; Abbate M; Testa D; Corna D; Taraboletti G; Vecchi A; Dong QG; Rollins BJ; Bertani T; Remuzzi G
J Am Soc Nephrol; 1997 May; 8(5):720-9. PubMed ID: 9176841
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
[TBL] [Abstract][Full Text] [Related]
17. Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice.
Yamauchi T; Ishibashi A; Shikata K; Tokuhara N; Seino K; Kobayashi S; Nagai M
J Pharmacol Exp Ther; 2005 Mar; 312(3):938-44. PubMed ID: 15615868
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice.
Tao X; Fan F; Hoffmann V; Longo NS; Lipsky PE
Arthritis Res Ther; 2006; 8(1):R24. PubMed ID: 16507125
[TBL] [Abstract][Full Text] [Related]
19. Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis.
Ble A; Mosca M; Di Loreto G; Guglielmotti A; Biondi G; Bombardieri S; Remuzzi G; Ruggenenti P
Am J Nephrol; 2011; 34(4):367-72. PubMed ID: 21876349
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease.
Kairaitis L; Wang Y; Zheng L; Tay YC; Wang Y; Harris DC
Kidney Int; 2003 Oct; 64(4):1265-72. PubMed ID: 12969144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
